Intel guides Q1 revenue and profit below estimates, stock drops

Intel guided Q1 revenue of $11.7B–$12.7B (midpoint below the $12.63B consensus) and breakeven EPS versus $0.06 expected, sending the stock down more than 6% after hours. The company reported Q4 revenue of $13.7B (beat $13.37B) and EPS of $0.15 (beat $0.08), while full-year revenue was $52.9B with EPS of $0.42; management warned that available supply should be at its lowest in Q1 before improving in Q2, underscoring near-term demand/supply constraints that pressure near-term outlook.

Analysis

Market structure: Intel’s Q1 supply-constrained guide (midpoint ~$12.2B vs $12.63B consensus) creates a near-term demand gap that benefits foundries and fabless leaders able to pick up displaced orders (TSM, NVDA, AMD, ASML). PC OEMs and Intel’s direct OEM partners are losers in Q1 if units can’t ship; expect 3–7% FY25 share shifts to AMD/NVIDIA in segments where Intel is capacity constrained. Cross-asset: expect immediate INTC-IV and credit-spread widening, mild Treasury inflow; semicap equities (ASML, LRCX) see positive sentiment while USD sensitivity is limited.

Risk assessment: Tail risks include a prolonged manufacturing outage, US-China export restrictions of EUV/advanced nodes, or a capital shortfall from mis-executing IDM2—each could shave >20% off INTC market cap. Time horizons: days—IV spike and equity gap down; weeks—analyst downgrades and OEM inventory adjustments; quarters—Q2 supply improvement is the key inflection (management flagged supply better in Q2). Hidden dependencies: Altera deconsolidation masks YoY comparability; OSAT/substrate bottlenecks and customer inventory cycles could amplify swings.

Trade implications: Direct play: medium-conviction short of INTC sized 2–4% portfolio via 1–3 month put spread (expect 8–15% downside if Q1 remains weak) or buy 3-month 0.30-delta puts. Pair trade: long AMD (2–3% weight) / short INTC (2% weight) to capture share shift in client and server; alternatively long NVDA vs short INTC for AI exposure reallocation. Sector rotation: rotate 3–6% from Intel into TSM, ASML, and select cloud names (AMZN, GOOGL) that will source alternative silicon; reduce PC OEM cyclicals that can’t meet demand.

Contrarian angles: The market may over-penalize INTC for a single-quarter supply trough—if Q2 supply normalizes, expect a >15% mean-reversion rally; consider tactical buying around Q2 production confirmation. Historical parallel: capacity-induced share losses have reversed when fabs ramped (Intel 2010s vs peers); downside risk persists if execution on node roadmap slips. Action risk: short squeezes or management buybacks around an oversold print could compress shorts—size positions to withstand a 10–20% counter-move.

Key Decisions for Investors

• Establish a tactical 2–3% portfolio short position in INTC via a 1–3 month put spread (buy 3-month 0.30-delta puts, sell 0.15-delta puts) to cap cost; target 8–15% downside if guidance weak persists through Q1, exit on confirmed Q2 supply improvement guidance or 15% realized gain.
• Initiate a 2–3% long position in AMD (ticker: AMD) and a 1–2% long in NVDA (ticker: NVDA) funded by trimming legacy Intel exposure; thesis: share capture in client/server and AI workloads during Intel’s Q1 supply gap, re-evaluate after Q2 earnings (April–June).
• Rotate 3–5% of semiconductor-capex exposure into semicap/supply chain leaders (ASML, ticker: ASML; LRCX) and TSM (ticker: TSM) with a 6–12 month horizon, expecting durable demand for alternate capacity; add on any INTC-driven sector weakness >10%.
• Avoid outright long INTC until management provides Q2+ supply cadence confirming recovery; consider buying a 6–9 month call spread (delta ~0.25) after Q2 print if supply/IDM2 milestones are met, targeting >20% upside on execution.
• Monitor four signals in next 30–60 days: (1) Q1 customer shipment data or OEM sell-through, (2) Intel wafer starts and OSAT throughput comments, (3) analyst revisions for FY26 consensus, (4) any US/China export policy changes—act (trim or add) within 48 hours of material changes.